読み込み中
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
最新データ
￥612
−￥18.00 · -2.86%
日中の時刻はJSTです。市場データは遅延する場合があります。
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
日中レンジ
現在 ￥612
52週レンジ
現在 ￥612
日中の時刻はJSTです。市場データは遅延する場合があります。
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
日中レンジ
現在 ￥612
52週レンジ
現在 ￥612
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（JPY） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 2.31億 JPY | 5444.6万 JPY | 6111.2万 JPY | 3.74億 JPY | 7.08億 JPY |
| 売上原価 | 1.53億 JPY | 5288.4万 JPY | 6149万 JPY | 1.51億 JPY | 1.4億 JPY |
| 粗利益 | 7840万 JPY | 156.2万 JPY | −37.8万 JPY | 2.24億 JPY | 5.68億 JPY |
| 研究開発 | — | 4.7億 JPY | 3.76億 JPY | 3.04億 JPY | 2.66億 JPY |
| 販売・一般管理 | 9.07億 JPY | 4.28億 JPY | 3.21億 JPY | 3.45億 JPY | 2.31億 JPY |
| 営業費用 | 9.07億 JPY | 8.98億 JPY | 6.97億 JPY | 6.49億 JPY | 4.98億 JPY |
| 受取利息 | 380.7万 JPY | 48万 JPY | 4万 JPY | 4.1万 JPY | 17.6万 JPY |
| 支払利息 | 1427.9万 JPY | 951.4万 JPY | 977.4万 JPY | 745.7万 JPY | 523.6万 JPY |
| 減価償却費と償却費 | 3549.4万 JPY | 3601.7万 JPY | 3812.2万 JPY | 5428.5万 JPY | 1849.6万 JPY |
| 営業利益 | −8.28億 JPY | −8.96億 JPY | −6.97億 JPY | −4.25億 JPY | 7057万 JPY |
| 純利益 | −7.64億 JPY | −8.72億 JPY | −5.89億 JPY | −4.74億 JPY | 1.43億 JPY |
会社概要が更新されました 2026年10月8日.
直近の発表実績
直近の発表実績
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
